Durable remission related to CAR-T persistence in R/R B-ALL and long-term persistence potential of prime CAR-T.
Shiqi L, Jiasi Z, Lvzhe C, Huailong X, Liping H, Lin L, Qianzhen Z, Zhongtao Y, Junjie S, Zucong C, Yingzi Z, Meiling W, Yunyan L, Linling W, Lihua F, Yingnian C, Wei Z, Yu L, Le L, Youcheng W, Dingsong Z, Yancheng D, Ping Y, Lihua Z, Xiaoping L, Xiaozhuang H, Zhongzheng Z, Zhi Y, Cheng Q, Sanbin W.
Shiqi L, et al. Among authors: lihua z.
Mol Ther Oncolytics. 2023 Apr 20;29:107-117. doi: 10.1016/j.omto.2023.04.003. eCollection 2023 Jun 15.
Mol Ther Oncolytics. 2023.
PMID: 37215385
Free PMC article.